CorMedix Schedule 13G/A: 4.62M Shares (5.89%)

CorMedix Inc. amendment reports that SHAIBATALHAMD AYMEN ABDALKADER beneficially owns 4,618,511 shares of Common Stock, representing 5.89% of the class, with sole voting and sole dispositive power over those shares.

Rhea-AI Filing Summary

CorMedix Inc. amendment reports that SHAIBATALHAMD AYMEN ABDALKADER beneficially owns 4,618,511 shares of Common Stock, representing 5.89% of the class, with sole voting and sole dispositive power over those shares. The filing is signed and dated 06/12/2026 as Amendment No. 5.

Key Figures

Amendment date: 06/12/2026 Shares beneficially owned: 4,618,511 shares Percent of class: 5.89%

3 metrics

Amendment date 06/12/2026 Signed date on Amendment No. 5

Shares beneficially owned 4,618,511 shares Amount reported in Item 4(a)

Percent of class 5.89% Percent of common stock reported in Item 4(b)

Key Terms

Schedule 13G/A, Beneficially owned, Sole power to vote

3 terms

Schedule 13G/A regulatory

"Amendment No. 5 CorMedix Inc. COMMON STOCK"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Beneficially owned financial

"Item 4. Ownership (a) Amount beneficially owned: 4,618,511"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole power to vote regulatory

"Number of shares as to which the person has (i) Sole power to vote: 4,618,511"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the CRMD Schedule 13G/A amendment disclose?

It discloses 4,618,511 shares beneficially owned, equal to 5.89% of the class. The filer reports sole voting and sole dispositive power over those shares and signed the amendment on 06/12/2026.

Who filed the CRMD ownership amendment and where is the filer located?

SHAIBATALHAMD AYMEN ABDALKADER filed the amendment. The filer lists a residence/business address in Riyadh, Saudi Arabia at the address shown in the filing.

Does the filing indicate any shared voting or dispositive power for the CRMD shares?

No. The filing states the filer has sole power to vote and sole power to dispose of 4,618,511 shares; shared voting and dispositive power fields are left blank.

What class and CUSIP are reported in the CRMD Schedule 13G/A amendment?

The filing reports Common Stock, par value $0.001 per share with CUSIP 21900C308. These identifiers appear on the cover page of the amendment.

What percentage of CorMedix outstanding stock does the filer report owning (CRMD)?

The filer reports ownership equal to 5.89% of the common stock class. That percentage is provided in Item 4(b) alongside the exact share count of 4,618,511.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/12/2026 - 01:24 PM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 5)

CorMedix Inc.

(Name of Issuer)

COMMON STOCK, PAR V ALUE $0.001 PER SHARE

(Title of Class of Securities)

21900C308

(CUSIP Number)

06/11/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 21900C308

1

Names of Reporting Persons

SHAIBATALHAMD AYMEN ABDALKADER

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

SAUDI ARABIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 4,618,511.00
6	Shared Voting Power
7	Sole Dispositive Power 4,618,511.00
8	Shared Dispositive Power

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,618,511.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.9 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: CorMedix Inc.
(b)	Address of issuer's principal executive offices: 389 INTERPACE PKWY, SUITE 450, PARSIPPANY, NEW JERSEY, 07054
Item 2.
(a)	Name of person filing: SHAIBATALHAMD AYMEN ABDALKADER
(b)	Address or principal business office or, if none, residence: 7852, Al Batinah, 2650, Al Woroud Dist., Riyadh 12253, Saudi Arabia
(c)	Citizenship: Saudi Arabia
(d)	Title of class of securities: COMMON STOCK, PAR V ALUE $0.001 PER SHARE
(e)	CUSIP No.: 21900C308
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 4,618,511
(b)	Percent of class: 5.89 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 4,618,511
	(ii) Shared power to vote or to direct the vote:
	(iii) Sole power to dispose or to direct the disposition of: 4,618,511
	(iv) Shared power to dispose or to direct the disposition of:
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

SHAIBATALHAMD AYMEN ABDALKADER

Signature:	SHAIBATALHAMD AYMEN ABDALKADER
Name/Title:	Individual
Date:	06/12/2026